Justine Koenigsberg

Justine Koenigsberg currently serves as the Head of Investor Relations at Kymera Therapeutics, a position held since July 2023. Prior to this role, Justine held extensive experience in corporate communications and investor relations, notably as Senior Vice President at Concert Pharmaceuticals, Inc. from March 2008 to May 2023, where Justine also served as Vice President. Justine was the President of NIRI Boston from 2009 to 2010 and held senior director roles at ViaCell and Transkaryotic Therapies, Inc. Justine began a career in corporate communications at Vertex Pharmaceuticals. Justine earned a Bachelor of Science in Business Administration from Northeastern University between 1990 and 1995.